The vast majority of men diagnosed with early-stage prostate cancer have surgery or other harsh treatments that can cause permanent side effects, but a study found that men in their 60s who had surgery did not live significantly longer than those whose cancers were merely monitored. Michael Barry, HMS clinical professor of medicine at Massachusetts General Hospital, is a study co-author. Anthony D’Amico, HMS professor of radiation oncology at Brigham and Women’s Hospital and Philip Kantoff, HMS professor of medicine at Dana-Farber Cancer Institute, are also quoted.
